文献速递白血病

急性髓系白血病整合诊断的力量与潜力

The power and potential of integrated diagnostics in acute myeloid leukaemia.
PubMed 文献 · Br J Haematol · 2019-12-06

该综述指出,急性髓系白血病(AML)的诊断已从单纯形态学评估发展为整合细胞形态学、细胞化学、免疫表型、细胞遗传学和分子遗传学的多学科模式。只有整合所有这些方法,才能对每个病例进行全面且互补的表征,这是优化AML诊断与管理的前提。文章讨论了精准医学背景下多学科诊断的必要性、新技术带来的全基因组分子洞察以及海量数据整合到常规实践中的挑战与机遇。

要点

  • AML诊断需整合形态学、免疫表型、细胞遗传学和分子遗传学等多学科方法。
  • 多学科整合诊断是优化AML诊断与管理的先决条件。
  • 全基因组分子技术带来海量数据,既是挑战也是推动AML个性化医疗的机遇。

核心结论

  • 多学科整合诊断是当今AML诊断与管理的必要条件,并在精准医学背景下将愈发重要。

研究设计与样本

  • 综述性文章,讨论AML诊断从单纯形态学评估向整合多学科诊断的演变及未来策略。

主要发现

  • 当前最先进的AML诊断依赖细胞形态学、细胞化学、免疫表型、细胞遗传学和分子遗传学。
  • 只有整合所有这些方法,才能对每个病例进行全面且互补的表征。
  • 近期技术进展可提供全基因组分子洞察,但产生的大量数据既是巨大挑战也是独特机遇。

临床怎么用

  • 临床应采用整合多学科诊断方法对AML病例进行全面表征,以支持最佳诊断与管理。
  • 需探索将全基因组分子技术产生的大量数据纳入常规实践的策略,为AML个性化医疗铺路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The field of acute myeloid leukaemia (AML) diagnostics, initially based solely on morphological assessment, has integrated more and more disciplines. Today, state-of-the-art AML diagnostics relies on cytomorphology, cytochemistry, immunophenotyping, cytogenetics and molecular genetics. Only the integration of all of these methods allows for a comprehensive and complementary characterisation of each case, which is prerequisite for optimal AML diagnosis and management. Here, we will review why multidisciplinary diagnostics is mandatory today and will gain even more importance in the future, especially in the context of precision medicine. We will discuss ideas and strategies that are likely to shape and improve multidisciplinary diagnostics in AML and may even overcome some of today's gold standards. This includes recent technical advances that provide genome-wide molecular insights. The enormous amount of data obtained by these latter techniques represents a great challenge, but also a unique chance. We will reflect on how this increase in knowledge can be incorporated into the routine to pave the way for personalised medicine in AML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Haferlach T, Schmidts I. The power and potential of integrated diagnostics in acute myeloid leukaemia. Br J Haematol. 2019. PMID: 31808952. doi:10.1111/bjh.16360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。